[go: up one dir, main page]

NO179125C - Preparat for forbedring av implantasjon av et embryo i uterus hos et hunnpattedyr - Google Patents

Preparat for forbedring av implantasjon av et embryo i uterus hos et hunnpattedyr

Info

Publication number
NO179125C
NO179125C NO914306A NO914306A NO179125C NO 179125 C NO179125 C NO 179125C NO 914306 A NO914306 A NO 914306A NO 914306 A NO914306 A NO 914306A NO 179125 C NO179125 C NO 179125C
Authority
NO
Norway
Prior art keywords
paf
uterus
embryo
pct
female mammal
Prior art date
Application number
NO914306A
Other languages
English (en)
Norwegian (no)
Other versions
NO914306L (no
NO914306D0 (no
NO179125B (no
Inventor
Christopher O'neill
Original Assignee
North Sydney Area Health Serv
Oneill Christopher
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by North Sydney Area Health Serv, Oneill Christopher filed Critical North Sydney Area Health Serv
Publication of NO914306D0 publication Critical patent/NO914306D0/no
Publication of NO914306L publication Critical patent/NO914306L/no
Publication of NO179125B publication Critical patent/NO179125B/no
Publication of NO179125C publication Critical patent/NO179125C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Retarders (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO914306A 1989-05-05 1991-11-01 Preparat for forbedring av implantasjon av et embryo i uterus hos et hunnpattedyr NO179125C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPJ405489 1989-05-05
PCT/AU1990/000183 WO1990013299A1 (fr) 1989-05-05 1990-05-07 Activation de la fertilite

Publications (4)

Publication Number Publication Date
NO914306D0 NO914306D0 (no) 1991-11-01
NO914306L NO914306L (no) 1992-01-03
NO179125B NO179125B (no) 1996-05-06
NO179125C true NO179125C (no) 1996-08-14

Family

ID=3773897

Family Applications (1)

Application Number Title Priority Date Filing Date
NO914306A NO179125C (no) 1989-05-05 1991-11-01 Preparat for forbedring av implantasjon av et embryo i uterus hos et hunnpattedyr

Country Status (9)

Country Link
US (1) US5240922A (fr)
EP (1) EP0473612B1 (fr)
KR (1) KR920700648A (fr)
AT (1) ATE140868T1 (fr)
CA (1) CA2054197A1 (fr)
DE (1) DE69027992D1 (fr)
HU (1) HUT60631A (fr)
NO (1) NO179125C (fr)
WO (1) WO1990013299A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0540766A1 (fr) * 1991-11-04 1993-05-12 Korth, Ruth-Maria, Dr. med Traitement des maladies induites par les éosinophiles avec des antagonistes du PAF, et procédé pour en déterminer l'efficacité
US5895785A (en) * 1987-10-20 1999-04-20 Ruth Korth Treatment and prevention of disorders mediated by LA-paf or endothelial cells
DE540767T1 (de) * 1991-11-04 2001-10-25 Ruth-Maria Korth Behandlung und Vorbeugung von von erhöhten Lyso-PAF-Spiegel mediierten mentalen Erkrankungen mit PAF-Antagonisten
GB9227123D0 (en) * 1992-12-30 1993-02-24 Applied Research Systems Method
US5599918A (en) * 1994-10-04 1997-02-04 La Jolla Cancer Research Foundation Nucleic acids encoding trophinin and trophinin-assisting proteins
US5654145A (en) * 1994-10-04 1997-08-05 La Jolla Cancer Research Foundation Trophinin and trophinin-assisting nucleic acids and methods of detection thereof
US6022563A (en) * 1998-02-04 2000-02-08 Superior Equine Pharmaceuticals, Inc. Phenylbutazone carrier formulation
WO2002085180A2 (fr) * 2001-04-18 2002-10-31 Family Health International Operation de vasectomie et kit correspondant
CA2447519C (fr) 2001-05-24 2008-09-16 Alexza Molecular Delivery Corporation Administration par voie pulmonaire d'alprazolam, d'estazolam, de midazolam ou de triazolam
CA2446904A1 (fr) 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Administration d'esters medicamenteux par inhalation
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
US7498019B2 (en) 2001-05-24 2009-03-03 Alexza Pharmaceuticals, Inc. Delivery of compounds for the treatment of headache through an inhalation route
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
DE602004030546D1 (de) * 2003-03-04 2011-01-27 Aspenbio Pharma Inc LH zur Verwendung der Erhaltung einer oder mehreren Schwangerschaften durch Induktion der Bildung des sekundären Gelbkörpers.
JP2007516404A (ja) 2003-05-21 2007-06-21 アレックザ ファーマシューティカルズ， インコーポレイテッド 光学点火されたかまたは電気点火された内蔵式加熱ユニットおよびそれを使用する薬剤供給ユニット
CA2536112A1 (fr) * 2003-08-20 2005-03-03 Northern Sydney And Central Coast Area Health Service Methodes pouvant ameliorer la viabilite d'un embryon
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
EP2246086A3 (fr) 2004-08-12 2012-11-21 Alexza Pharmaceuticals, Inc. Dispositif d'administration de médicament en aérosol comprenant une unité de chauffage allumée par percussion
US20070087055A1 (en) * 2005-10-14 2007-04-19 David Jan Directly compressible extended release alprazolam formulation
EP2121088B1 (fr) 2007-03-09 2016-07-13 Alexza Pharmaceuticals, Inc. Unité chauffante à utiliser dans un dispositif d'administration de médicament
WO2010010201A1 (fr) 2008-07-22 2010-01-28 Equipo Ivi Investigacion Sl Profil d'expression génétique utilisé comme marqueur de la réceptivité endométriale
US20110021591A1 (en) * 2009-07-21 2011-01-27 Gordon Douglas J Phenylbutazone carrier formulation showing increased bioactivity in animals
WO2012008467A1 (fr) 2010-07-12 2012-01-19 株式会社エリナ Composition pharmaceutique pour promouvoir une ostéogénèse contenant un lignane axial équatorial du type furofurane orienté aryle, et préparation pharmaceutique, produit alimentaire fonctionnel et un produit alimentaire diététique comprenant la composition
PL3569697T3 (pl) 2014-06-17 2022-07-04 Asherman Therapy, S.L. Terapia komórkami macierzystymi w patologiach endometrium
KR102852740B1 (ko) 2018-02-02 2025-08-29 알렉스자 파마스티칼즈, 인크. 전기적 응축 에어로졸 디바이스

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973603A (en) * 1988-06-16 1990-11-27 Sumner Burstein Platelet activating factor antagonist and methods of use therefor

Also Published As

Publication number Publication date
NO914306L (no) 1992-01-03
HUT60631A (en) 1992-10-28
EP0473612A1 (fr) 1992-03-11
WO1990013299A1 (fr) 1990-11-15
NO914306D0 (no) 1991-11-01
ATE140868T1 (de) 1996-08-15
EP0473612A4 (en) 1992-11-19
EP0473612B1 (fr) 1996-07-31
NO179125B (no) 1996-05-06
HU9004445D0 (en) 1992-02-28
US5240922A (en) 1993-08-31
KR920700648A (ko) 1992-08-10
CA2054197A1 (fr) 1990-11-06
DE69027992D1 (de) 1996-09-05

Similar Documents

Publication Publication Date Title
NO179125C (no) Preparat for forbedring av implantasjon av et embryo i uterus hos et hunnpattedyr
GR3019315T3 (en) Use of nervonic acid and long chain fatty acids for the treatment of demyelinating disorders
DE3855113D1 (de) Verwendung von Buspiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung der Alkoholsucht
GR3032037T3 (en) Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them
ATE113834T1 (de) Zusammensetzung zur behandlung der schizophrenie.
DE69033487D1 (de) Behandlung von autoimmunkrankheiten durch verabreichung von autoantigenen in form von aerosol
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
NO176549C (no) Fremgangsmåte for fremstilling av L-dopa-kjerner med 2 overtrekk
PT74928A (en) New anti-thromboticum based on polysachatides method for its preparation and pharmaceutical compositions
ATE150301T1 (de) Aminoalkanesulfonsäurederivate und pharmazeutische zusammensetzungen davon zur prävention oder behandlung von herzerkrankungen
AU625561B2 (en) Method and composition for preventing conception
ATE246515T1 (de) Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
ATE93388T1 (de) Paracetamol enthaltende arzneizubereitung.
GR3001793T3 (en) Polyprenyl alcohol-containing injections and use thereof
DK527186A (da) Bronchodilaterende farmaceutisk praeparat
DK0472534T3 (da) Somatotropin til forøgelse af fertiliteten hos dyr
DE59409413D1 (de) Verwendung von n,s-diacetylcystein-ethylester (dacee) zur herstellung eines medikaments zur behandlung viraler erkrankungen
ATE213634T1 (de) Verwendung von prostaglandinen zur herstellung eines arzneimittels zur prävention und behandlung des sekundären katarakts
Thomas et al. The early development of palatal rugae in the rat
DE3279264D1 (en) Method of immunizing pigs against aujeszky's disease
ATE153859T1 (de) Somatotropin zur erhoehung der reproduktiven leistung in rinder
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
SE9001592L (sv) Terapeutisk komposition
TNSN94110A1 (fr) Procede de preparation de compositions orales contenant des quinolones
Gardner et al. The development of the elbow joint of the chick and its correlation with embryonic staging